1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsHereditary Hemorrhagic Telangiectasia (HHT) Center is sponsored by Health Resources & Services Administration (HRSA). Provides funding for centers specializing in the treatment of HHT.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
A **. gov** website belongs to an official government organization in the United States.
* How to Apply for Grants * **Applicant Resources** * Adobe Software Compatibility * Submitting UTF-8 Special Characters * Encountering Error Messages * Grantor Standard Language * Submitting UTF-8 Special Characters * **Applicant System-To-System** * Reference Implementation * **Grantor System-To-System** * Reference Implementation * SF-424 Individual Family * SF-424 Mandatory Family * SF-424 Short Organization Family * Post-Award Reporting Forms * Country and State Lists Updates * **Manage Subscriptions** * Program Management Office * Grants.
gov Maintenance Calendar View similar opportunities Hereditary Hemorrhagic Telangiectasia (HHT) Center Department of Health and Human Services Health Resources and Services Administration Document Type:Grants Notice Funding Opportunity Number:HRSA-26-092 Funding Opportunity Title:Hereditary Hemorrhagic Telangiectasia (HHT) Center Opportunity Category:Discretionary Opportunity Category Explanation: Funding Instrument Type:Cooperative Agreement Category of Funding Activity:Health Expected Number of Awards:1 Assistance Listings:93.
110 -- Special Projects of Regional and National Significance Cost Sharing or Matching Requirement:No Last Updated Date:Jun 08, 2026 Original Closing Date for Applications:Jul 10, 2026 Electronically submitted applications must be submitted no later than 11:59 p. m. , ET, on the listed application due date.
Current Closing Date for Applications:Jul 10, 2026 Electronically submitted applications must be submitted no later than 11:59 p. m. , ET, on the listed application due date.
Archive Date:Aug 30, 2026 Estimated Total Program Funding:$ 2,900,000 Eligible Applicants:State governments Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" Additional Information on Eligibility:"Domestic" means the 50 states, the District of Columbia, the Commonwealth of Puerto Rico, the Northern Mariana Islands, American Samoa, Guam, the U.S. Virgin Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau.
## Additional Information Agency Name:Health Resources and Services Administration Description:The purpose of the Hereditary Hemorrhagic Telangiectasia (HHT) Center Program is to reduce illness and death related to HHT by partnering with clinical center to expand access and coordination of care; creating innovative strategies that support clinicians with identifying and diagnosing HHT cases; and developing a de-identified, aggregate patient data registry to better understand this rare disease and its treatment outcomes.
Link to Additional Information:[](https://www. grants. gov/search-results-detail/361511) Grantor Contact Information:If you have difficulty accessing the full announcement electronically, please contact: ## Similar Opportunities (identified by AI) #### Health & Human Services * Frequently Asked Questions ## Your session will expire in 3 minutes.
To continue working, click on the "OK" button below. This is being done to protect your privacy. Unsaved changes will be lost.
According to the current listing, eligibility includes: Domestic public or private nonprofit entities. Confirm the full requirements in the official notice before applying.
The published deadline was July 10, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Hereditary Hemorrhagic Telangiectasia (HHT) Center is funded by Health Resources & Services Administration (HRSA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
HHS announced $102 million in New Access Points awards on August 13, 2026 — 158 health centers, more than 415 new sites, nearly 1 million more patients. That works out to roughly $246,000 per site, which does not build a clinic. Here is what the award actually buys, why the real selection happened before applications were scored, and what unfunded applicants should do next.
Read articleThe FY2026 Rural Health Network Advancement Program (HRSA-26-082) offers six awards of roughly $500,000 to help independent rural hospitals and clinics form integrated networks without surrendering local ownership. With a July 24, 2026 deadline and a pilot design that rewards genuine collaboration over merger, here is who qualifies, what a fundable network looks like, and how small rural providers should approach it.
Read articlePMHCA (HRSA-26-058) makes $9.79 million available for up to 22 awards of up to $445,000 to build tele-consultation networks that help pediatric primary care providers manage children's behavioral health. The catch buried in the eligibility section: applicants must NOT already hold a PMHCA award — which effectively reserves the new-state lane for the eight unfunded states and territories, plus tribes everywhere. Here's how to read it and what wins.
Read article